CERo Therapeutics reports cash balance of ~$5.5M as of Jan 7, 2025 after warrant exercises and equity line sales

CERO THERAPEUTICS HOLDINGS, INC.

Cash balance of approximately $5.463 million as of January 7, 2025.
Funds raised through warrant exercises for Series A Preferred Stock and sales under committed equity financing facility.
Filing updates prior 8-K on Dec 31, 2024; no other material changes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.